scholarly article | Q13442814 |
P819 | ADS bibcode | 2015PLoSO..1035295M |
P356 | DOI | 10.1371/JOURNAL.PONE.0135295 |
P932 | PMC publication ID | 4530969 |
P698 | PubMed publication ID | 26258949 |
P5875 | ResearchGate publication ID | 281478262 |
P2093 | author name string | Kenneth A Fields | |
Konrad E Mueller | |||
P2860 | cites work | Integration of PCR fragments at any specific site within cloning vectors without the use of restriction enzymes and DNA ligase | Q74238681 |
Genome Sequence of an Obligate Intracellular Pathogen of Humans: Chlamydia trachomatis | Q22065557 | ||
Type III protein secretion systems in bacterial pathogens of animals and plants | Q24548602 | ||
A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin | Q24564460 | ||
Conditional gene expression in Chlamydia trachomatis using the tet system | Q27304592 | ||
A C. trachomatis cloning vector and the generation of C. trachomatis strains expressing fluorescent proteins under the control of a C. trachomatis promoter | Q27313656 | ||
Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescence-based reporter | Q37008377 | ||
Interaction of chlamydiae and host cells in vitro | Q37056842 | ||
Genus-optimized strategy for the identification of chlamydial type III secretion substrates | Q37337255 | ||
New frontiers in type III secretion biology: the Chlamydia perspective | Q37548120 | ||
Expression and targeting of secreted proteins from Chlamydia trachomatis. | Q37713167 | ||
Expression of the effector protein IncD in Chlamydia trachomatis mediates recruitment of the lipid transfer protein CERT and the endoplasmic reticulum-resident protein VAPB to the inclusion membrane | Q37713377 | ||
The transcriptional repressor EUO regulates both subsets of Chlamydia late genes | Q37843504 | ||
Evolution, phylogeny, and molecular epidemiology of Chlamydia. | Q37844970 | ||
The early gene product EUO is a transcriptional repressor that selectively regulates promoters of Chlamydia late genes | Q37848768 | ||
Virulence blockers as alternatives to antibiotics: type III secretion inhibitors against Gram-negative bacteria | Q37857710 | ||
Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron | Q37859892 | ||
A directed screen for chlamydial proteins secreted by a type III mechanism identifies a translocated protein and numerous other new candidates | Q37864748 | ||
Requirement for the Rac GTPase in Chlamydia trachomatis invasion of non-phagocytic cells. | Q37867232 | ||
Evidence for the secretion of Chlamydia trachomatis CopN by a type III secretion mechanism. | Q37875136 | ||
Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. | Q37877960 | ||
Tracking bacterial pathogens with genetically-encoded reporters. | Q38214489 | ||
Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli | Q40007146 | ||
The Chlamydia trachomatis type III secretion chaperone Slc1 engages multiple early effectors, including TepP, a tyrosine-phosphorylated protein required for the recruitment of CrkI-II to nascent inclusions and innate immune signaling | Q28539981 | ||
Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (HemG) and Chlamydia trachomatis infectivity | Q30449313 | ||
Mechanisms of host cell exit by the intracellular bacterium Chlamydia | Q30480273 | ||
Chlamydia trachomatis type III secretion: evidence for a functional apparatus during early-cycle development. | Q30916655 | ||
Multifunctional analysis of Chlamydia-specific genes in a yeast expression system | Q31034927 | ||
Human GCIP interacts with CT847, a novel Chlamydia trachomatis type III secretion substrate, and is degraded in a tissue-culture infection model | Q33285974 | ||
The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex | Q33502747 | ||
Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes | Q33578702 | ||
Deep sequencing-based discovery of the Chlamydia trachomatis transcriptome | Q33633681 | ||
The Coxiella burnetii Dot/Icm system delivers a unique repertoire of type IV effectors into host cells and is required for intracellular replication | Q33921269 | ||
Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector | Q34037667 | ||
Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates. | Q34048332 | ||
Alveolar macrophages and neutrophils are the primary reservoirs for Legionella pneumophila and mediate cytosolic surveillance of type IV secretion. | Q34298593 | ||
Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development | Q34383783 | ||
Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins | Q34491620 | ||
Identification of novel type III secretion chaperone-substrate complexes of Chlamydia trachomatis | Q34595020 | ||
Role for chlamydial inclusion membrane proteins in inclusion membrane structure and biogenesis | Q34733854 | ||
The Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion system substrates | Q34740733 | ||
The trans-Golgi SNARE syntaxin 6 is recruited to the chlamydial inclusion membrane. | Q34837395 | ||
Effector protein modulation of host cells: examples in the Chlamydia spp. arsenal | Q34920157 | ||
Characterization of interactions between inclusion membrane proteins from Chlamydia trachomatis | Q35072279 | ||
The Chlamydial Type III Secretion Mechanism: Revealing Cracks in a Tough Nut. | Q35075114 | ||
Identification of type III secretion substrates of Chlamydia trachomatis using Yersinia enterocolitica as a heterologous system | Q35095777 | ||
Advances in genetic manipulation of obligate intracellular bacterial pathogens | Q35155325 | ||
Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis | Q35168447 | ||
Plague bacteria target immune cells during infection | Q35535438 | ||
The Chlamydia trachomatis parasitophorous vacuolar membrane is not passively permeable to low-molecular-weight compounds | Q35544513 | ||
Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms | Q35577557 | ||
Chlamydial type III secretion system is encoded on ten operons preceded by sigma 70-like promoter elements | Q35634235 | ||
Rapid, accurate, computational discovery of Rho-independent transcription terminators illuminates their relationship to DNA uptake | Q35751629 | ||
Domain analyses reveal that Chlamydia trachomatis CT694 protein belongs to the membrane-localized family of type III effector proteins | Q36201930 | ||
Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis | Q36445214 | ||
Induction of type III secretion by cell-free Chlamydia trachomatis elementary bodies | Q36992556 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Chlamydia trachomatis | Q131065 |
P304 | page(s) | e0135295 | |
P577 | publication date | 2015-08-10 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Application of β-lactamase reporter fusions as an indicator of effector protein secretion during infections with the obligate intracellular pathogen Chlamydia trachomatis | |
P478 | volume | 10 |
Q26775890 | A Coming of Age Story: Chlamydia in the Post-Genetic Era |
Q60302097 | A FACS-Based Genome-wide CRISPR Screen Reveals a Requirement for COPI in Chlamydia trachomatis Invasion |
Q36594034 | A working model for the type III secretion mechanism in Chlamydia |
Q40093677 | Applying Fluorescence Resonance Energy Transfer (FRET) to Examine Effector Translocation Efficiency by Coxiella burnetii during siRNA Silencing. |
Q52715453 | Characterization of Chlamydial Rho and the Role of Rho-Mediated Transcriptional Polarity during Interferon-gamma-mediated Tryptophan Limitation. |
Q36950792 | Chlamydia cell biology and pathogenesis |
Q37834184 | Chlamydia trachomatis Transformation and Allelic Exchange Mutagenesis |
Q92562686 | Chlamydia trachomatis and Chlamydia muridarum spectinomycin resistant vectors and a transcriptional fluorescent reporter to monitor conversion from replicative to infectious bacteria |
Q37642082 | Development of a Proximity Labeling System to Map the Chlamydia trachomatis Inclusion Membrane |
Q36902486 | Emancipating Chlamydia: Advances in the Genetic Manipulation of a Recalcitrant Intracellular Pathogen |
Q37833951 | Engineering of obligate intracellular bacteria: progress, challenges and paradigms |
Q52430804 | Feasibility of a Conditional Knockout System for Chlamydia Based on CRISPR Interference. |
Q44058928 | Fluorescence-Reported Allelic Exchange Mutagenesis Reveals a Role for Chlamydia trachomatis TmeA in Invasion That Is Independent of Host AHNAK. |
Q36496540 | Gene Deletion by Fluorescence-Reported Allelic Exchange Mutagenesis in Chlamydia trachomatis |
Q42369614 | Identification of a strong and specific antichlamydial N-acylhydrazone. |
Q37836353 | One Face of Chlamydia trachomatis: The Infectious Elementary Body |
Q92576287 | Proximity Labeling To Map Host-Pathogen Interactions at the Membrane of a Bacterium-Containing Vacuole in Chlamydia trachomatis-Infected Human Cells |
Q38884653 | SepG coordinates sporulation-specific cell division and nucleoid organization in Streptomyces coelicolor |
Q64990918 | Structural basis for the homotypic fusion of chlamydial inclusions by the SNARE-like protein IncA. |
Q57294646 | THE EXPANDING MOLECULAR GENETICS TOOLKIT IN |
Q55344798 | The Loss of Expression of a Single Type 3 Effector (CT622) Strongly Reduces Chlamydia trachomatis Infectivity and Growth. |
Q90138180 | The multiple functions of the numerous Chlamydia trachomatis secreted proteins: the tip of the iceberg |
Q33740626 | Tracking Proteins Secreted by Bacteria: What's in the Toolbox? |
Q50152277 | Transformation of Chlamydia: Current approaches and impact on our understanding of chlamydial infection biology. |
Q37835620 | Use of Group II Intron Technology for Targeted Mutagenesis in Chlamydia trachomatis |
Q35809465 | Use of aminoglycoside 3' adenyltransferase as a selection marker for Chlamydia trachomatis intron-mutagenesis and in vivo intron stability |
Search more.